ADVERTISEMENT

Company News

  • January 30, 2013 - 8:57 PM

NEW PRODUCTS

St. Jude Medical Inc., Little Canada, announced the enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN Renal Denervation System in patients with uncontrolled hypertension.

© 2014 Star Tribune